[
1. Abu-Amer Y., Darwech I.: Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 2007, 9 (Suppl 1), S6.10.1186/ar2170
]Search in Google Scholar
[
2. Åstrand J., Aspenberg P.: Reduction of instabilityinduced bone resorption using bisphosphonates. High doses are needed in rats. Acta Orthop Scand 2002, 73, 24-30.10.1080/000164702317281369
]Search in Google Scholar
[
3. Bexheti D., Anderson E.I., Hutt A.J., Brown M.A.: Evaluation of multidimensional capillary electrophoretic methodologies for determination of amino bisphosphonate pharmaceuticals. J Chromatograph A 2006, 1130, 137-14.10.1016/j.chroma.2006.06.110
]Search in Google Scholar
[
4. Bock O., Börst H., Beller G., Armbrecht G., Degner C., Martus P., Roth H.J., Felsenberg D.: Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT. Bone 2012, 50, 317-24.10.1016/j.bone.2011.10.027
]Search in Google Scholar
[
5. Daley-Yates P., Gifford L., Hoggarth C.: Assay of 1- hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography. J Chromatogr B: Biomed Sci Appl 1989, 490, 329-338.10.1016/S0378-4347(00)82791-7
]Search in Google Scholar
[
6. Fleisch H.: Bisphosphonates: mechanisms of action. Endcrinol Rev 1998, 19, 80-102.10.1210/edrv.19.1.03259494781
]Search in Google Scholar
[
7. Frith J.C., Monkkonen J., Blackburn G.M., Russell R.G., Rogers M.J.: Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5’-(β, γ-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997, 12, 1358-1367.10.1359/jbmr.1997.12.9.13589286751
]Search in Google Scholar
[
8. Gao Y., Zou S., Liu X., Bao Ch., Jing H.: The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 2009, 30, 1790-1796.10.1016/j.biomaterials.2008.12.02519135249
]Search in Google Scholar
[
9. Geoffroy V., Paschalis E.P., Libouban H., Blouin S., Ostertag A., Chappard D., Cros M., Phipps R., de Vernejoul M.C.: Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. Calcif Tissue Int 2011, 88, 464-475.10.1007/s00223-011-9480-621455736
]Search in Google Scholar
[
10. Goldring S.R., Gravallese E.M.: Bisphosphonates: environmental protection for the joint? Arthritis Rheum 2004, 50, 2044-2047.10.1002/art.2038315248201
]Search in Google Scholar
[
11. Goodship A.E., Blunn G.W., Green J., Coathup M.J.: Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate. J Orthop Res 2008, 26, 693-703.10.1002/jor.20533
]Search in Google Scholar
[
12. Huikko K., Kostiainen R.: Development and validation of a capillary zone electrophoresis method for the determination of bisphosphonate and phosphonate impurities in clodronate. J Chromatogr A 2000, 893, 411-420.10.1016/S0021-9673(00)00753-6
]Search in Google Scholar
[
13. Jakobsen T., Bass J., Bechtold J.E., Elmengaard B., Soballe K.: Soaking morselized allograft bone in bisphosphonate can impair implant fixation. Clin Orthop 2007, 463, 195-201.10.1097/BLO.0b013e31813c6696
]Search in Google Scholar
[
14. Jia H.J., Li W., Zhao K.: Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Anal Chim Acta 2006, 562, 171-175.10.1016/j.aca.2006.01.077
]Search in Google Scholar
[
15. Kwong E., Chiu A.M.Y., McClintock S.A., Cotton M.L.: HPLC analysis of an amino bisphosphonate in pharmaceutical formulations using post-column derivatization and fluorescence detection. J Chromatogr Sci 1990, 28, 563-566.10.1093/chromsci/28.11.563
]Search in Google Scholar
[
16. Lewis G., Janna S.: Aldendronate in bone cement. Clin Orthop Rel Res 2006, 445, 233-238.10.1097/01.blo.0000201162.59819.28
]Search in Google Scholar
[
17. Makkonen N., Hirvonen M-R., Teräväinen T., Savolainen K., Mönkönen J.: Different effects of three bisphosphonates on nitric oxide production by Raw 264 macrophage-like cells in vitro. J Pharm Exp Ther 1996, 277, 1097-1102.
]Search in Google Scholar
[
18. Marx R.E.: Pamidronate (Aredia) and zoledronate (Zometa) induced a vascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 2003, 61, 1115-1117.10.1016/S0278-2391(03)00720-1
]Search in Google Scholar
[
19. Matuszewski Ł., Matuszewska A., Mazurkiewicz T., Rogalski J., Cho N.S., Ohga S.: Determination of bisphosphonates by ion-pair HPLC. J Fac Agr Kyushu Univ 2011, 56, 213-216.10.5109/20311
]Search in Google Scholar
[
20. Matuszewski Ł, Turżańska K, Matuszewska A, Jabłoński M, Polkowska I, Mazurkiewicz T.: Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using microcomputed tomography. International Orthopaedics. http://www.springer.com/alert/urltracking.do?id=Lfb8d2bMbe6f65Saad8ca1. Accessed 24 February 2013.10.1007/s00264-013-1855-z366416923503639
]Search in Google Scholar
[
21. Mazurkiewicz T., Matuszewski Ł., Matuszewska A., Jaszek M.: Implanted bisphosphonates in bone cement affect bone markers in rat serum. International Orthopaedics. http://link.springer.com/article/10.1007/s00264-013-1816-6. Accessed 26 January 2013.10.1007/s00264-013-1816-6363149823404413
]Search in Google Scholar
[
22. Migliorati C.A.: Bisphosphonates and oral cavity bone necrosis. J Clin Oncol 2003, 21, 4253-4254.10.1200/JCO.2003.99.132
]Search in Google Scholar
[
23. Morris C.D., Einhorn T.A.: Bisphosphonates in orthopedic surgery. J. Bone Joint Surg 2005, 87, 1609-1618.10.2106/00004623-200507000-00028
]Search in Google Scholar
[
24. Perjesi P., Kim T., Zharikova A.D., Li X., Ramesh T., Ramasubbu J., Prokai L.: Determination of clodronate content in liposomal formulation by capillary zone electrophoresis. J Pharma Biomed Anal 2003, 31, 929-935.10.1016/S0731-7085(02)00673-8
]Search in Google Scholar
[
25. Peter B., Gauthier O., Laib S., Bujoli B., Guicheux J., Janvier P.: Local delivery of bisphosphonate from coated orthopedic implants increases implant mechanical stability in osteoporotic rats. J Biomed Mater Res A 2006, 76, 133-143.10.1002/jbm.a.30456
]Search in Google Scholar
[
26. Prieto-Alhambra D., Javaid M., Judge A., Murray D., Carr A., Cooper C., Arden N.: Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 2011. http://dx.doi.org/10.1136/bmj.d722.
]Search in Google Scholar
[
27. Rodriquez J.A.B., Desimone M.F., Iglesias S.L., Giorgieri S.A., Diaz L.E.: Validation of a capillary electrophoresis method for the analysis of ibandronate related impurities. J Pharm Biomed Anal 2007, 44, 305-308.10.1016/j.jpba.2007.02.021
]Search in Google Scholar
[
28. Russell R.G.G., Rogers M.J.: Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999, 25, 97-106.10.1016/S8756-3282(99)00116-7
]Search in Google Scholar
[
29. Schindeler A., Birke O., Yu N.Y., Morse A., Ruys A., Baldock P.A., Little D.G.: Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. J Bone Joint Surg Br 2011, 93, 1134-1139.10.1302/0301-620X.93B8.25940
]Search in Google Scholar
[
30. Sirén H., Määttänen A., Riekkola M.L.: Determination of small anions by capillary electrophoresis using indirect UV detection with sulphonated nitrosonaphtol dyes. J Chromatogr A 1997, 767, 293-301.10.1016/S0021-9673(96)01036-9
]Search in Google Scholar
[
31. Sparidans R.W., Hartigh J.: Chromatographic analysis of bisphosphonates. Pharm World Sci 1999, 21, 1-10.10.1023/A:1008646810555
]Search in Google Scholar
[
32. Tomlin J.L., Sturgeon C., Pead M.J., Muir P.: Use of bisphosphonate drug aldendronate for palliative management of osteosarcoma in two dogs. Vet Rec 2000, 147, 129-132.10.1136/vr.147.5.12910958534
]Search in Google Scholar
[
33. Wilkinson J.M., Little D.G.: Bisphosphonates in orthopedic applications. Bone 2011, 49, 95-102.10.1016/j.bone.2011.01.00921256254
]Search in Google Scholar
[
34. Viereck V., Emons G., Lauck V., Frosch K.H., Blaschke S., Grundker C., Hofbauer L.: Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002, 291, 680-668.10.1006/bbrc.2002.651011855844
]Search in Google Scholar
[
35. Xie Z.X., Jiang Y., Zhang D.Q.: Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion- pairing agent. J Chromatogr 2006, 1104, 173-178.10.1016/j.chroma.2005.11.11316376909
]Search in Google Scholar
[
36. Xuenong Z., Qingyun X., Haishengen L., Bunger M., Lind M., Bunger C.: Effect of alendronate on bone in growth into porous tantalum and carbon fiber interbody devices. Acta Orthop Scand 2003, 74, 596-603.10.1080/0001647031001802714620983
]Search in Google Scholar
[
37. Zacharis C.K., Tzanavaras P.D.: Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: A review of analytical methods. J Pharma Biomed Anal 2008, 48, 483-496.10.1016/j.jpba.2008.05.02818599247
]Search in Google Scholar
